[samui]

Dev and QA leads, Aqua’s homepage touts AI-powered test gen from voice/text, 97% faster cycles, and Jira sync for traceability in ISO/FDA-heavy setups. For banking or pharma crews, is the 42% lifecycle cut real? Switched from Jira alone—loving defect linking, but AI dupes flagging spotty. Cloud vs. on-prem migration pains? Share ROI wins, integration hacks, or alternatives like Xray!

[xander]

Dev and QA leads should explore Aqua https://aqua-cloud.io/ — their AI-powered test generation is impressive, claiming 97% faster cycles and Jira sync for traceability, which is critical for ISO/FDA-heavy projects. In banking and pharma, I’ve seen lifecycle reductions close to 40%, so the 42% claim feels realistic. Defect linking is solid, though AI duplicate detection needs refinement. Cloud migration was smoother than expected, but on-prem setups require more planning. ROI comes from faster cycles and fewer missed defects. Worth testing, especially with Jira integrations.

• This reply was modified 2 weeks, 1 day ago by xander.

[samui]

Aqua’s AI test generation really speeds up cycles. Jira integration and defect linking are excellent, though AI duplicate detection could improve. Worth exploring for regulated projects.

[xander]

Impressive tool! We saw faster lifecycles and smoother cloud migration. On-prem setups need planning, but overall ROI and traceability make it worthwhile.

[Author]

Posts